The results showed that the serum NUCB2/nesfatin‐1 cut‐off point of 939.07 pg/mL showed a 100% sensitivity and a 83.3% specificity, indicating that serum NUCB2/nesfatin‐1 has a superior diagnostic value in GC. This evidence concerns the gene NUCB2 and gastric cancer.